| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.079 | 0.1 |